American College of Clinical Pharmacy
      Search      Cart

Clinical Reasoning Series in Critical Care Pharmacy - Managing Cardiovascular Therapies in the Critically Ill

Monday, October 28, 2019 from 8:30 AM to 4:30 PM EDT at 2nd Floor: Sutton Center/South

Clinical Reasoning Series in Critical Care has been approved by the Board of Pharmacy Specialties for the recertification of Board Certified Critical Care Pharmacy Specialists (BCCCPSs). BCCCPs are involved in managing cardiovascular related medication therapies. They are often responsible for assessing and developing drug therapy regimens for critically ill patients with acute cardiovascular related complications or supportive devices. Acute heart failure, thrombosis, bleeding and increasing application of devices have become common challenges in the intensive care unit. Critically ill patients with notable cardiovascular conditions are at high risk for organ related complications, adverse medication events and related morbidity and mortality that in many cases can be avoided. As our understanding of more optimal approaches to assessment tools and how to approach disease state management evolves, BCCCPs need to engage as prospective as possible using evidence-based strategies that frequently have to be individualized to the complexity and frequently understudied critically ill patient. The complexity of managing these conditions and common occurrences of special populations, this program will address current evidence-based strategies and summarize their place in contemporary patient care. The program will consist of several educational activities and include practice skills, current evidence and management approaches. Topics to be covered include acute heart failure and related support strategies, atrial fibrillation, thrombosis management, coagulopathies, hemorrhagic emergencies and anticoagulation reversal. Each activity will discuss treatment strategies and application of skills to knowledge in developing management plans. Participants will have the opportunity to attend one or both educational activities. Each activity will offer 3.0 contact hours of continuing pharmacy education credit toward BCCCP recertification credit upon completion of a required posttest by the submission deadline and achievement of a predetermined passing score.